HONG KONG – A proposed annual adjustment on the pricing of pharmaceuticals and medical devices in Japan backfired after manufacturers publicly opposed it. A multicountry coalition of organizations said the changes would inhibit growth and investment in the entire health care sector, impede innovation and adversely impact access by patients.